Immatics presenting at 5th Annual Allogeneic Cell Therapies Summit
May 22 - May 25, 2023
Join us at the 5th Annual Allogeneic Cell Therapies Summit to discuss the specific challenges in the development of allogeneic CAR-T, TCR, NK, Gamma-Delta, and iPSC therapies.
Wednesday, May 24, 4:30 PM (EST)
- Session: Ushering in the Next Wave of Universal Cell Therapy – Future Directions
- Presentation: Developing Next-Generation Allogeneic Therapies for Solid Tumors Based on γδ T cells
Discussing characteristics of gamma delta T cells as source for an allogeneic cell therapy approach
Redirecting gamma delta T cells with TCRs against peptide-HLA targets to combat solid tumors
Exploring next-gen strategies to potentiate anti-tumor activity
- Presenter: Ali Mohamed, Senior VP CMC, Immatics
We are looking forward to meeting you!
For more information visit the event's homepage.
Boston, MA, USA